Catalog: | C0844T |
Product Type: | Test kit |
Unit: | 96 tests |
Regulatory status: | EU: CE |
Incubation time: | 2 x 30 min, 1 x 15 min |
Standard range: | 6.25 - 100 µlU/Ml |
Sample type: | Plasma, serum |
Sample requirements: | 25 µL |
Isotope/Substrate: | TMB 450 nm |
Analysis mode: | ELISA |
Application: | Metabolic Syndrome |
Insulin is the principal hormone responsible for the control of glucose metabolism. Secretion of insulin is mainly controlled by plasma glucose concentration, and the hormone has a number of important metabolic actions. Its principal function is to control the uptake and utilisation of glucose in peripheral tissues via the glucose transporter. This and other hypoglycaemic activities, such as the inhibition of hepatic gluconeogenesis and glycogenolysis are counteracted by the hyperglycaemic hormones including glucagon, epinephrine (adrenaline), growth hormone and cortisol. Insulin concentrations are severely reduced in insulin-dependent diabetes mellitus (IDDM) and some other conditions such as hypopituitarism. Insulin levels are raised in non-insulin-dependent diabetes mellitus (NIDDM), obesity, insulinoma and some endocrine dysfunctions such as Cushing s syndrome and acromegaly.
Copyright © 2024 Creative Biogene. All rights reserved.